|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Litigation settlement | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense), net: | |||||
| Interest and investment income, net | |||||
| Interest expense | |||||
| Other income, net | |||||
| Interest income (expense), net | |||||
| Change in fair value of derivative liability | |||||
| Foreign currency transaction gain (loss), net | |||||
| Total other income, net | |||||
| Net loss | |||||
| Net loss per share, basic | |||||
| Net loss per share of common stock diluted | |||||
| Weighted average number of common shares outstanding, basic | |||||
| Weighted average number of common shares outstanding, diluted | |||||
| Net Income Loss | |||||
| Other comprehensive income (loss): | |||||
| Change in unrealized (loss) gain on marketable debt securities | |||||
| Total other comprehensive (loss) income | |||||
| Total comprehensive loss | |||||
Loading...